# Sebaceous Carcinoma as a Presentation of Muir-Torre Syndrome

**Authors:** Emily Saurborn, Bukola Adeshina, Isabella G Stuart, Shane Cook

PMC · DOI: 10.7759/cureus.77386 · Cureus · 2025-01-13

## TL;DR

A case of sebaceous carcinoma is presented as a sign of Muir-Torre Syndrome, a rare genetic condition linked to Lynch syndrome and multiple cancers.

## Contribution

The paper highlights sebaceous carcinoma as a rare but important clinical presentation of Muir-Torre Syndrome.

## Key findings

- A sebaceous adenocarcinoma was identified in a patient with Muir-Torre Syndrome.
- Immunohistochemistry showed loss of MSH2 and MLH1, supporting the diagnosis.
- The case underscores the importance of recognizing sebaceous tumors in MTS evaluation.

## Abstract

Muir-Torre syndrome (MTS) is a rare, autosomal dominant condition that is within the spectrum of Lynch syndrome (hereditary nonpolyposis colorectal cancer (HNPCC)). Sebaceous adenomas are among the most specific manifestations of MTS. Other malignancies include tumors of the colon, rectum, and genitourinary systems, such as endometrial, ovarian, urothelial, and prostate cancer. Individuals at risk for MTS are identified using the Mayo score, which assesses risk based on family history of Lynch syndrome-associated cancers, personal history of these cancers, and age at diagnosis of a sebaceous adenoma or visceral malignancy. We present a case of a firm, red-yellow papule on the upper extremity, which was revealed by a biopsy to be a sebaceous adenocarcinoma. Immunohistochemistry was significant for the loss of MSH2 and MLH1.

## Linked entities

- **Proteins:** MSH2 (mutS homolog 2), MLH1 (mutL homolog 1)
- **Diseases:** Muir-Torre syndrome (MONDO:0008018), Lynch syndrome (MONDO:0005835), hereditary nonpolyposis colorectal cancer (MONDO:0018630), sebaceous adenocarcinoma (MONDO:0006962), endometrial cancer (MONDO:0002447), ovarian cancer (MONDO:0005140), prostate cancer (MONDO:0005159)

## Full-text entities

- **Genes:** MLH1 (mutL homolog 1) [NCBI Gene 4292] {aka COCA2, FCC2, HNPCC, HNPCC2, LYNCH2, MLH-1}, MSH2 (mutS homolog 2) [NCBI Gene 4436] {aka COCA1, FCC1, HNPCC, HNPCC1, LCFS2, LYNCH1}
- **Diseases:** MTS (MESH:D055653), tumors of the colon, rectum, (MESH:D003110), endometrial, ovarian, urothelial, and prostate cancer (MESH:D011472), Sebaceous Carcinoma (MESH:D012626), Lynch syndrome-associated cancers (MESH:D009369), papule (MESH:D000169), Sebaceous adenomas (MESH:D000236), autosomal dominant condition (MESH:C566739), sebaceous adenocarcinoma (MESH:D018266), Lynch syndrome (MESH:D003123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11821365/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11821365/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC11821365/full.md

---
Source: https://tomesphere.com/paper/PMC11821365